C2B tumours have no recurrent mutations but display frequent gains of chromosome 7, as well as a downregulation of the tumour suppressor DLK1-MEG3 miRNA cluster following LOH at the 14q32 locus, also encountered in the C2C group. Here, MEG3 is linked to neoplasm.